Causeway Therapeutics

Developer of microRNA-based therapies for tendinopathy, cardiovascular diseases, and skin aging

placeGlasgow, Scotland, United Kingdom calendar_todayFounded 2017 groups9 employees language causewaytx.com

Registered entities

Innovation

2 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 79 times.

YearFilings
20221
20231
20242
20251

Investor mix

4 investors on record; lead investors include University of Glasgow, Scottish Enterprise, Mediqventures.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%
Coming soon